HORAN Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
HORAN Wealth's BMY Position: Q3 2026 in Review
HORAN Wealth increased its Bristol-Myers Squibb (BMY) stake by 121% in Q3 2026, buying an estimated $728K and bringing the position to 21,016 shares worth $1.31M. The position accounts for 0.13% of the portfolio, ranked #94.
HORAN Wealth first reported a position in BMY in Q3 2025 and has held it in 5 quarters since. 2,570 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- HORAN Wealth held 21,016 shares of Bristol-Myers Squibb worth $1.31M as of Q3 2026.
- HORAN Wealth bought 11,525 Bristol-Myers Squibb shares in Q3 2026, an estimated $728K.
- Bristol-Myers Squibb made up 0.13% of HORAN Wealth's portfolio in Q3 2026, its #94 holding.
- HORAN Wealth first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 5 quarters since.
- 2,570 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on HORAN Wealth's 13F filing for Q3 2026, filed 12 Nov 2026.